Who Supplies Digoxin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Digoxin exports, with 203+ registered manufacturers shipping to buyers across 104+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 29.4% (export value: $640.1K). Close behind, SUN PHARMACEUTICAL INDUSTRIES LTD (4.6%, $99.5K). ACME GENERICS LLP (3.3%, $72.7K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Digoxin? Top Manufacturers & Their Buyers
Flow of Digoxin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Digoxin Supplier Network — Key Market Intelligence
The Digoxin export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 29.4% share, shipping $640.1K worth of product across 53 shipments. The second-largest exporter, SUN PHARMACEUTICAL INDUSTRIES LTD, contributes $99.5K (4.6%) to the overall market. Combined, the top two suppliers alone account for 33.9% of all Digoxin exports, indicating a relatively concentrated supply base.
Across all 203 tracked manufacturers, the total Digoxin export value stands at $2.2M from 886 shipments. The market average shipment value is $2.5K. The single largest buyer relationship in terms of trade value is NORTHSTAR DISTRIBUTION CENTER, receiving $349.0K worth of product.
The combined buyer network spans 7 named purchasing companies, including NORTHSTAR DISTRIBUTION CENTER, SUN PHARMACEUTICAL INDUSTRIESINC., JAMP PHARMA CORPORATION, ACTIVO INGREDINETS PTE LTD., PEOPLES BANK and 2 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Digoxin exporter from India, with a market share of 29.4% and a total export value of $640.1K across 53 shipments. Their average shipment value of $12.1K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. NORTHSTAR DISTRIBUTION CENTER is the dominant customer, accounting for 54.5% of this supplier's tracked business. Top customers include:
• NORTHSTAR DISTRIBUTION CENTER — $349.0K across 29 shipments (54.5% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIESINC. — $85.9K across 7 shipments (13.4% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIESINC. — $79.4K across 7 shipments (12.4% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER — $68.7K across 6 shipments (10.7% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER — $57.1K across 5 shipments (8.9% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $12.1K is 391% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
2SUN PHARMACEUTICAL INDUSTRIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD is the second-largest Digoxin exporter from India, with a market share of 4.6% and a total export value of $99.5K across 8 shipments. Their average shipment value of $12.4K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LTD serves 2 named buyers in our database. NORTHSTAR DISTRIBUTION CENTER is the dominant customer, accounting for 54.4% of this supplier's tracked business. Top customers include:
• NORTHSTAR DISTRIBUTION CENTER — $54.2K across 4 shipments (54.4% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIESINC. — $45.4K across 4 shipments (45.6% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LTD's per-shipment value of $12.4K is 406% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
3ACME GENERICS LLP
ACME GENERICS LLP is the third-largest Digoxin exporter from India, with a market share of 3.3% and a total export value of $72.7K across 4 shipments. Their average shipment value of $18.2K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
ACME GENERICS LLP serves 2 named buyers in our database. JAMP PHARMA CORPORATION is the dominant customer, accounting for 70.7% of this supplier's tracked business. Top customers include:
• JAMP PHARMA CORPORATION — $51.4K across 3 shipments (70.7% of this supplier's total exports)
• JAMP PHARMA CORPORATION — $21.3K across 1 shipments (29.3% of this supplier's total exports)
Key Insight: ACME GENERICS LLP's per-shipment value of $18.2K is 639% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
4UNICURE REMEDIES PRIVATE LIMITED
UNICURE REMEDIES PRIVATE LIMITED is the fourth-largest Digoxin exporter from India, with a market share of 2.9% and a total export value of $64.2K across 21 shipments. Their average shipment value of $3.1K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
UNICURE REMEDIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ACTIVO INGREDINETS PTE LTD. — $25.9K across 8 shipments (40.3% of this supplier's total exports)
• PEOPLES BANK — $12.8K across 4 shipments (19.9% of this supplier's total exports)
• TO THE ORDER OF SEYL — $9.1K across 3 shipments (14.2% of this supplier's total exports)
• METRO PHARMACEUTICAL — $8.5K across 3 shipments (13.2% of this supplier's total exports)
• ACTIVO INGREDINETS PTE LTD. — $7.9K across 3 shipments (12.4% of this supplier's total exports)
Key Insight: UNICURE REMEDIES PRIVATE LIMITED's per-shipment value of $3.1K is 24% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
5VENOR PHARMA LIMITED
VENOR PHARMA LIMITED is the fifth-largest Digoxin exporter from India, with a market share of 1.8% and a total export value of $39.9K across 7 shipments. Their average shipment value of $5.7K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
VENOR PHARMA LIMITED serves 1 named buyer in our database. TO THE ORDER OF is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $39.9K across 7 shipments (100.0% of this supplier's total exports)
Key Insight: VENOR PHARMA LIMITED's per-shipment value of $5.7K is 132% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
6CARITAS HEALTHCARE PRIVATE LIMITED
CARITAS HEALTHCARE PRIVATE LIMITED is the fifth-largest Digoxin exporter from India, with a market share of 1.8% and a total export value of $38.7K across 3 shipments. Their average shipment value of $12.9K is above the market average of $2.5K, suggesting premium or bulk contract pricing.
CARITAS HEALTHCARE PRIVATE LIMITED serves 1 named buyer in our database. F.D.E.C.A is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• F.D.E.C.A — $38.7K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: CARITAS HEALTHCARE PRIVATE LIMITED's per-shipment value of $12.9K is 424% above the market average of $2.5K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Digoxin Flows
Once Digoxin leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LTD, it travels to 5 destination markets with a combined import value of $2.2M. United States absorbs the largest share at 51.4% ($1.1M), followed by Sri Lanka (5.7%) and Venezuela (5.3%).
In United States — the top destination — named importers include NORTHSTAR DISTRIBUTION CENTER 8912, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC.
This geographic spread reflects Digoxin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Digoxin Go? Top Importing Countries & Their Buyers
Trade flow of Digoxin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Digoxin imports from India, with a total trade value of $1.1M across 61 shipments — representing a 51.4% share of all Digoxin exports. The average shipment value of $18.4K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Digoxin importers in United States: NORTHSTAR DISTRIBUTION CENTER 8912 is the largest buyer, accounting for 53.3% ($597.5K) of this market's total imports.
• NORTHSTAR DISTRIBUTION CENTER 8912 — $597.5K (53.3% of United States's total)
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $259.1K (23.1% of United States's total)
• SUN PHARMACEUTICAL INDUSTRIES INC — $124.8K (11.1% of United States's total)
Key Insight: United States's per-shipment average of $18.4K (647% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Digoxin imports from India.
2Sri Lanka
Sri Lanka ranks as the second-largest destination for Digoxin imports from India, with a total trade value of $124.7K across 0 shipments — representing a 5.7% share of all Digoxin exports. The average shipment value of $124.7K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations.
Key Insight: Sri Lanka's per-shipment average of $124.7K (4971% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Digoxin imports from India.
3Venezuela
Venezuela ranks as the third-largest destination for Digoxin imports from India, with a total trade value of $115.9K across 6 shipments — representing a 5.3% share of all Digoxin exports. The average shipment value of $19.3K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Digoxin importers in Venezuela: LEBOO HEALTHCARE PRODUCTS C.A is the largest buyer, accounting for 22.6% ($26.2K) of this market's total imports.
• LEBOO HEALTHCARE PRODUCTS C.A — $26.2K (22.6% of Venezuela's total)
Key Insight: Venezuela's per-shipment average of $19.3K (685% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Venezuela is a key market for Digoxin imports from India.
4Canada
Canada ranks as the fourth-largest destination for Digoxin imports from India, with a total trade value of $95.5K across 8 shipments — representing a 4.4% share of all Digoxin exports. The average shipment value of $11.9K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Digoxin importers in Canada: JAMP PHARMA CORPORATION is the largest buyer, accounting for 76.1% ($72.7K) of this market's total imports.
• JAMP PHARMA CORPORATION — $72.7K (76.1% of Canada's total)
• JAMP PHARMA CORP. — $22.8K (23.9% of Canada's total)
Key Insight: Canada's per-shipment average of $11.9K (385% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Digoxin imports from India.
5Nigeria
Nigeria ranks as the fifth-largest destination for Digoxin imports from India, with a total trade value of $72.8K across 4 shipments — representing a 3.3% share of all Digoxin exports. The average shipment value of $18.2K is above the global average of $2.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Digoxin importers in Nigeria: GREAT TIMEC PHARMA COMPANY LIMITED is the largest buyer, accounting for 38.8% ($28.2K) of this market's total imports.
• GREAT TIMEC PHARMA COMPANY LIMITED — $28.2K (38.8% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $18.2K (640% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Digoxin imports from India.
People Also Ask — Digoxin Supplier & Trade Network
Who are the top suppliers of Digoxin from India?+
Which companies buy Digoxin from Indian manufacturers?+
Where does Digoxin exported from India go?+
What is the market share of the top Digoxin supplier from India?+
What is the average shipment value for Digoxin exports from India?+
Is Digoxin manufactured in India and exported globally?+
Which country imports the most Digoxin from India?+
Who are the buyers of Digoxin in Sri Lanka?+
How concentrated is the Digoxin supplier market in India?+
How do I find verified buyers for Digoxin in specific countries?+
Digoxin Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Digoxin exporter with a 29.4% market share and $640.1K in total exports — making it the single most important sourcing entity in this market.
- 2The top 203 suppliers collectively account for 43.8% of all tracked Digoxin exports, with a combined trade value of $2.2M.
- 3United States is the largest destination market, absorbing 51.4% of India's Digoxin exports ($1.1M). Sri Lanka (5.7%) and Venezuela (5.3%) follow.
- 4With 886 total shipments averaging $2.5K each, the Digoxin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include NORTHSTAR DISTRIBUTION CENTER, SUN PHARMACEUTICAL INDUSTRIESINC., NORTHSTAR DISTRIBUTION CENTER, SUN PHARMACEUTICAL INDUSTRIESINC. — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 104 countries
Network value: $2.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Digoxin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Digoxin.
- 2.Flow Mapping: 203 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 886 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 104 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
886 Verified Shipments
203 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists